Insulin and glucose‐lowering agents for treating people with diabetes and chronic kidney disease

BACKGROUND: Diabetes is the commonest cause of chronic kidney disease (CKD). Both conditions commonly co‐exist. Glucometabolic changes and concurrent dialysis in diabetes and CKD make glucose‐lowering challenging, increasing the risk of hypoglycaemia. Glucose‐lowering agents have been mainly studied...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Cochrane Database Syst Rev
Asıl Yazarlar: Lo, Clement, Toyama, Tadashi, Wang, Ying, Lin, Jin, Hirakawa, Yoichiro, Jun, Min, Cass, Alan, Hawley, Carmel M, Pilmore, Helen, Badve, Sunil V, Perkovic, Vlado, Zoungas, Sophia
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: John Wiley & Sons, Ltd 2018
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6513625/
https://ncbi.nlm.nih.gov/pubmed/30246878
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD011798.pub2
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller